Antithrombin III Congenital Defects: Revising Classification System

• References

• 1 Sas G. Classification of antithrombin III deficiencies. Has a new tower of Babel been built?. Thromb Haemostas 1988; 60: 530-531
• 2 Leone G, De Stefano V, Di Donfrancesco A, Ferrelli R, Traisci G, Bizzi B. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern. Br J Haematol 1987; 65: 187-191
• 3 Leone G, Cotumaccio R, De Stefano V, Zanetti L. Antithrombin III Roma: a familial quantitative-qualitative AT III deficiency identifiable by crossed immunoelectrofocusing and by crossed immunoelectrophoresis. Haematologica 1983; 68: 765-774
• 4 De Stefano V, Leone G, Ferrelli R, Di Donfrancesco A, De Martini D, Bizzi B. Further characterization of a pathological isoantithrombin with no affinity to heparin (Antithrombin III Roma). Thromb Res 1987; 48: 23-30
• 5 Sas G. Defects in serine protease inhibitors. Thromb Haemostas 1987; 58: 248 (Abstr)
• 6 Gomperts ED, Feesey M, Van der Walt JD. Two dimensional immunoelectrophoretic studies in anti-thrombin III deficiency. Thromb Res 1976; 8: 713-718
• 7 Sas G, Peto I, Banhegyi D, Blasko G, Domjan G. Heterogeneity of the “classical” antithrombin III deficiency. Thromb Haemostas 1980; 43: 133-136
• 8 Grau E, Fontcuberta J, Felez J, de Diego I, Soto R, Rutllant MLI. AT III Barcelona: a familial quantitative-qualitative AT III deficiency. Thromb Haemostas 1988; 59: 13-17
• 9 Hultin MB, McKay J, Abildgaard U. Antithrombin Oslo: type lb classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants. Thromb Haemostas 1988; 59: 468-473
• 10 Fontcuberta J, Grau E, Rubio N, Felez J, Rutllant MLI. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called AT III - Barcelona 2. Thromb Res 1988; 51: 75-81
• 11 Bock SC, Marrinan JA, Radziejewska E. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site. Biochemistry 1988; 27: 6171-6178
• 12 Leone G, De Stefano V, Ferrelli R, Teofili L, Tengborn L, Vahtera E, Bizzi B. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing. Thromb Haemostas 1988; 60: 8-12
• 13 Nagy I, Losonczy H, Szaksz I, Temesi C, Hergert K. An analysis of clinical and laboratory data in patients with congenital antithrombin III (AT III) deficiency. Acta Med Hung 1979; 36: 53-60
• 14 Carrell RW, Boswell DR. Serpins: the superfamily of plasma serine proteinase inhibitors. In: Proteinase Inhibitors. Barrett A, Salvesen G. (eds) Elsevier; Amsterdam: 1986: 403-420
• 15 Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Boswell DR. Structure and variation of human alpha-1-antitrypsin. Nature 1982; 298: 329-334
• 16 Sas G. Hereditary antithrombin III deficiency: biochemical aspects. Haematologia 1984; 17: 81-86
• 17 Erdjument H, Lane DA, Panico M, Di Marzo V, Morris HR. Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in Antithrombin Northwick Park and to histidine in Antithrombin Glasgow. J Biol Chem 1988; 263: 5589-5593
• 18 Erdjument H, Lane DA, Ireland H, Di Marzo V, Panico M, Morris HR, Tripodi A, Mannucci PM. Antithrombin Milano, single amino acid substitution at the reactive site, Arg³⁹³ to Cys. Thromb Haemostas 1988; 60: 471-475
• 19 Stephens AW, Thalley BS, Hirs CH W. Antithrombin-III Denver, a reactive site variant. J Biol Chem 1987; 262: 1044-1048
• 20 Murayama H, Matsuda M. Abnormal properties and behaviours of antithrombin III found in a thrombophilic patient: defective biological functions and dissimilar antigenic determinants. Thromb Haemostas 1986; 56: 165-171